Literature DB >> 15095008

Caffeine as a psychomotor stimulant: mechanism of action.

G Fisone1, A Borgkvist, A Usiello.   

Abstract

The popularity of caffeine as a psychoactive drug is due to its stimulant properties, which depend on its ability to reduce adenosine transmission in the brain. Adenosine A(1) and A(2A) receptors are expressed in the basal ganglia, a group of structures involved in various aspects of motor control. Caffeine acts as an antagonist to both types of receptors. Increasing evidence indicates that the psychomotor stimulant effect of caffeine is generated by affecting a particular group of projection neurons located in the striatum, the main receiving area of the basal ganglia. These cells express high levels of adenosine A(2A) receptors, which are involved in various intracellular processes, including the expression of immediate early genes and regulation of the dopamine- and cyclic AMP-regulated 32-kDa phosphoprotein DARPP-32. The present review focuses on the effects of caffeine on striatal signal transduction and on their involvement in caffeine-mediated motor stimulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15095008     DOI: 10.1007/s00018-003-3269-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  98 in total

Review 1.  Genetics of caffeine consumption and responses to caffeine.

Authors:  Amy Yang; Abraham A Palmer; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2010-06-09       Impact factor: 4.530

2.  Polymorphisms of ADORA2A modulate psychomotor vigilance and the effects of caffeine on neurobehavioural performance and sleep EEG after sleep deprivation.

Authors:  S Bodenmann; C Hohoff; C Freitag; J Deckert; J V Rétey; V Bachmann; H-P Landolt
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 3.  Drug-induced sleep: theoretical and practical considerations.

Authors:  Jeffrey M Ellenbogen; Edward F Pace-Schott
Journal:  Pflugers Arch       Date:  2011-09-28       Impact factor: 3.657

4.  Occurrence of pharmaceuticals, hormones, and perfluorinated compounds in groundwater in Taiwan.

Authors:  Yen-Ching Lin; Webber Wei-Po Lai; Hsin-hsin Tung; Angela Yu-Chen Lin
Journal:  Environ Monit Assess       Date:  2015-04-16       Impact factor: 2.513

5.  Pathway-specific effect of caffeine on protection against UV irradiation-induced apoptosis in corneal epithelial cells.

Authors:  Ling Wang; Luo Lu
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

6.  Influence of coffee drinking and cigarette smoking on the risk of primary late onset blepharospasm: evidence from a multicentre case control study.

Authors:  G Defazio; D Martino; G Abbruzzese; P Girlanda; M Tinazzi; G Fabbrini; C Colosimo; M S Aniello; L Avanzino; M Buccafusca; G Majorana; C Trompetto; P Livrea; A Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-06-19       Impact factor: 10.154

Review 7.  Adenosine A2A receptors and basal ganglia physiology.

Authors:  S N Schiffmann; G Fisone; R Moresco; R A Cunha; S Ferré
Journal:  Prog Neurobiol       Date:  2007-06-26       Impact factor: 11.685

Review 8.  Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.

Authors:  Christopher J Edgar; Edward F Pace-Schott; Keith A Wesnes
Journal:  Hum Psychopharmacol       Date:  2009-07       Impact factor: 1.672

9.  Association between coffee consumption and total dietary caffeine intake with cognitive functioning: cross-sectional assessment in an elderly Mediterranean population.

Authors:  Indira Paz-Graniel; Nancy Babio; Nerea Becerra-Tomás; Estefania Toledo; Lucia Camacho-Barcia; Dolores Corella; Olga Castañer-Niño; Dora Romaguera; Jesús Vioque; Ángel M Alonso-Gómez; Julia Wärnberg; J Alfredo Martínez; Luís Serra-Majem; Ramon Estruch; Francisco J Tinahones; Fernando Fernandez-Aranda; José Lapetra; Xavier Pintó; Josep A Tur; Antonio García-Rios; Aurora Bueno-Cavanillas; José J Gaforio; Pilar Matía-Martín; Lidia Daimiel; Vicente Martín Sánchez; Josep Vidal; Lucía Prieto-Sanchez; Emilio Ros; Cristina Razquin; Cristina Mestres; José V Sorli; Aida M Cuenca-Royo; Angel Rios; Laura Torres-Collado; Jessica Vaquero-Luna; Napoleon Pérez-Farinós; M Angeles Zulet; Almudena Sanchez-Villegas; Rosa Casas; M Rosa Bernal-Lopez; José Manuel Santos-Lozano; Xavier Corbella; David Mateos; Pilar Buil-Cosiales; Susana Jiménez-Murcia; Rebeca Fernandez-Carrion; Laura Forcano-Gamazo; Meritxell López; Miguel Ángel Sempere-Pascual; Anai Moreno-Rodriguez; Alfredo Gea; Rafael de la Torre-Fornell; Jordi Salas-Salvadó
Journal:  Eur J Nutr       Date:  2020-10-30       Impact factor: 5.614

Review 10.  Caffeine as an attention enhancer: reviewing existing assumptions.

Authors:  Suzanne J L Einöther; Timo Giesbrecht
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.